Here’s what you need to know.
1. Neovasc is an advanced biological tissue business.
2. Boston Scientific is acquiring certain manufacturing assets and capabilities, and will integrate them into its structural heart business for use in Boston Scientific’s Lotus Valve System.
3. As part of the deal, Boston Scientific is taking a 15 percent ownership in Neovasc.
More articles on gastroenterology/endoscopy:
FDA awards 510(k) clearance to DiLumen: 4 things to know
GI leader to know: Dr. Sidney Neimark of the Digestive Center of the Palm Beaches
IBD monitoring index may pave the way for GI mobile health: 3 study insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
